Stock Analysts

Jazz Submits NDA to FDA for JZP-110 to Cure Sleep Disorder

Jazz Pharmaceuticals plc JAZZ announced that it has submitted a new drug application to the FDA for its lead pipeline candidate, JZP-110 (solriamfetol), for treatment of excessive sleepiness (“ES”) in adult patients with narcolepsy or obstructive sleep apnea (“OSA”). JZP-110 is being evaluated in a phase III TONES program for treatment of OSA and narcolepsy. The TONES program comprises four studies. […]

Stock Analysts

Here’s Why You Should Buy Medifast (MED) Stock Right Now

It goes without saying that the food industry has been suffering from lower sales owing to the changing eating pattern of consumers and their preference for healthy, fresh and organic food products. That said, overlooking the industry will not be prudent as there are several companies with a decent performance history and strong fundamentals, signaling at a profitable investment opportunity. After all, year-end seasonal factors will continue to drive stocks higher. […]

Stock Analysts

Why is Nektar (NKTR) Stock Up More Than 350% This Year?

Shares of Nektar Therapeutics NKTR have skyrocketed almost 368% this year so far, substantially outperforming the industry ’s increase of 8.2%. Let’s analyze the factors that led to this massive rally. Nektar’s rapid progress on a robust pipeline this year including several study initiations with positive readouts and strategic collaborations has driven its share price consistently. […]

Stock Analysts

Meredith Up 26% in 3 Months: Will the Rally Continue in 2018?

Meredith Corporation MDP has been in investors’ good books for a while now. In fact, the company has been riding high on its strategic acquisitions, robust initiatives and impressive earnings surprise history. Shares of this Zacks Rank #2 (Buy) company have gained 25.5% in the last three months, outperforming the Zacks Publishing-Periodicals industry ’s growth of 18.2%. […]

Stock Analysts

Here’s Why it is Time to Add POSCO (PKX) to Your Portfolio

We issued an updated research report on South Korean steel producer POSCO PKX on Dec 22, 2017. We believe that a diversified business structure, initiatives to improve competitiveness in steel production, focus on growth of other businesses and strengthening steel demand make this stock an attractive choice for investors seeking exposure in the steel industry. The stock carries a Zacks Rank #2 (Buy) […]

Stock Analysts

Can Moody’s (MCO) Stellar Performance Continue in 2018?

Moody's Corporation MCO continues to be a leading provider of credit ratings, research, data & analytical tools, software solutions and related risk management services across the globe. Post the dismal 2016 performance, the company made a comeback this year. Before we dig into the factors that are likely to support the rally in 2018, let’s first check out what the factors which drove the stock this year […]